Terms: = Bone cancer AND MAF, MGC71685, 4094, ENSG00000178573
58 results:
1. Metastasis prevention with bone-targeted agents: a complex interaction between the microenvironment and tumour biology.
Coleman R
J Bone Miner Metab; 2023 May; 41(3):290-300. PubMed ID: 37162605
[TBL] [Abstract] [Full Text] [Related]
2. Identification of long noncoding RNA
Chen T; Sun Z; Cui Y; Ji J; Li Y; Qu X
Hematology; 2023 Dec; 28(1):2164449. PubMed ID: 36657019
[TBL] [Abstract] [Full Text] [Related]
3. Plasma cell neoplasms and related entities-evolution in diagnosis and classification.
Fend F; Dogan A; Cook JR
Virchows Arch; 2023 Jan; 482(1):163-177. PubMed ID: 36414803
[TBL] [Abstract] [Full Text] [Related]
4. C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse.
Yang LX; Zhang CT; Yang MY; Zhang XH; Liu HC; Luo CH; Jiang Y; Wang ZM; Yang ZY; Shi ZP; Yang YC; Wei RQ; Zhou L; Mi J; Zhou AW; Yao ZR; Xia L; Yan JS; Lu Y
Blood; 2023 Feb; 141(7):766-786. PubMed ID: 36322939
[TBL] [Abstract] [Full Text] [Related]
5. ZNF750 facilitates carcinogenesis via promoting the expression of long non-coding RNA
Xia L; Lin H; Zhou Y; Lian J
J Zhejiang Univ Sci B; 2022 Jul; 23(7):587-596. PubMed ID: 35794688
[TBL] [Abstract] [Full Text] [Related]
6. Targeting the oncogenic transcription factor c-maf for the treatment of multiple myeloma.
Jiang Q; Mao H; He G; Mao X
Cancer Lett; 2022 Sep; 543():215791. PubMed ID: 35700821
[TBL] [Abstract] [Full Text] [Related]
7. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients.
Tian K; Qi W; Yan Q; Lv M; Song D
Invest New Drugs; 2022 Aug; 40(4):818-830. PubMed ID: 35435626
[TBL] [Abstract] [Full Text] [Related]
8. Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study.
Cheng Y; Li Y; Scherer N; Grundner-Culemann F; Lehtimäki T; Mishra BH; Raitakari OT; Nauck M; Eckardt KU; Sekula P; Schultheiss UT;
PLoS Genet; 2022 Apr; 18(4):e1010139. PubMed ID: 35385482
[TBL] [Abstract] [Full Text] [Related]
9. Local anesthetic levobupivacaine inhibits stemness of osteosarcoma cells by epigenetically repressing mafB though reducing KAT5 expression.
Wang Z; Song Y; Zhang H; Yang Y; Zhang S; Wang W
Aging (Albany NY); 2022 Mar; 14(6):2793-2804. PubMed ID: 35333774
[TBL] [Abstract] [Full Text] [Related]
10. Non-Invasive Profiling of Advanced Prostate cancer via Multi-Parametric Liquid Biopsy and Radiomic Analysis.
Morrison G; Buckley J; Ostrow D; Varghese B; Cen SY; Werbin J; Ericson N; Cunha A; Lu YT; George T; Smith J; Quinn D; Duddalwar V; Triche T; Goldkorn A
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269713
[TBL] [Abstract] [Full Text] [Related]
11. Oestradiol Contributes to Differential Antitumour Effects of Adjuvant Zoledronic Acid Observed Between Pre- and Post-Menopausal Women.
Canuas-Landero VG; George CN; Lefley DV; Corness H; Muthana M; Wilson C; Ottewell PD
Front Endocrinol (Lausanne); 2021; 12():749428. PubMed ID: 34733240
[TBL] [Abstract] [Full Text] [Related]
12.
Paterson AHG; Lucas PC; Anderson SJ; Mamounas EP; Brufsky A; Baez-Diaz L; King KM; Lad T; Robidoux A; Finnigan M; Sampayo M; Tercero JC; Mairet JJ; Wolff AC; Fehrenbacher L; Wolmark N; Gomis RR
JNCI Cancer Spectr; 2021 Aug; 5(4):. PubMed ID: 34377934
[TBL] [Abstract] [Full Text] [Related]
13. Loss of the maf Transcription Factor in Laryngeal Squamous Cell Carcinoma.
Janiszewska J; Bodnar M; Paczkowska J; Ustaszewski A; Smialek MJ; Szylberg L; Marszalek A; Kiwerska K; Grenman R; Szyfter K; Wierzbicka M; Giefing M; Jarmuz-Szymczak M
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356658
[TBL] [Abstract] [Full Text] [Related]
14. Correlation between targeted RNAseq signature of breast cancer CTCs and onset of bone-only metastases.
Lovero D; D'Oronzo S; Palmirotta R; Cafforio P; Brown J; Wood S; Porta C; Lauricella E; Coleman R; Silvestris F
Br J Cancer; 2022 Feb; 126(3):419-429. PubMed ID: 34272498
[TBL] [Abstract] [Full Text] [Related]
15. Functional analysis of large maf transcription factors and elucidation of their relationships with human diseases.
Takahashi S
Exp Anim; 2021 Aug; 70(3):264-271. PubMed ID: 33762508
[TBL] [Abstract] [Full Text] [Related]
16. Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma.
Jia Y; Zhou J; Tan TK; Chung TH; Wong RWJ; Chooi JY; Lim JSL; Sanda T; Ooi M; De Mel S; Soekojo C; Chen Y; Zhang E; Cai Z; Shen P; Ruan J; Chng WJ
Blood Cancer J; 2021 Feb; 11(2):32. PubMed ID: 33579893
[TBL] [Abstract] [Full Text] [Related]
17. High-risk cytogenetics in multiple myeloma: Further scrutiny of deletions within the IGH gene region enhances risk stratification.
Smith SC; Althof PA; Dave BJ; Sanmann JN
Genes Chromosomes Cancer; 2020 Oct; 59(10):569-574. PubMed ID: 32447782
[TBL] [Abstract] [Full Text] [Related]
18. Exome sequencing in 38 patients with intracranial aneurysms and subarachnoid hemorrhage.
Sauvigny T; Alawi M; Krause L; Renner S; Spohn M; Busch A; Kolbe V; Altmüller J; Löscher BS; Franke A; Brockmann C; Lieb W; Westphal M; Schmidt NO; Regelsberger J; Rosenberger G
J Neurol; 2020 Sep; 267(9):2533-2545. PubMed ID: 32367296
[TBL] [Abstract] [Full Text] [Related]
19. High maf of EGFR mutations and high ratio of T790M sensitizing mutations in ctDNA predict better third-generation TKI outcomes.
Li Y; Zhang F; Yuan P; Guo L; Jianming Y; He J
Thorac Cancer; 2020 Jun; 11(6):1503-1511. PubMed ID: 32285618
[TBL] [Abstract] [Full Text] [Related]
20. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
[TBL] [Abstract] [Full Text] [Related]
[Next]
